ACET Aceto Corporation

ACETO SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Aceto Corporation - ACET

NEW ORLEANS--(BUSINESS WIRE)--

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 25, 2018 to file lead plaintiff applications in a securities class action lawsuit against Aceto Corporation (NasdaqGS: ACET), if they purchased the Company’s shares between August 25, 2017 and April 18, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.

What You May Do

If you purchased shares of Aceto and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-acet/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by June 25, 2018.

About the Lawsuit

Aceto and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On April 18, 2018, the Company disclosed wide-ranging negative financial news, including that its “financial guidance issued on February 1, 2018, should no longer be relied upon”; it anticipates recording impairment charges of “$230 million to $260 million” on certain products; it was negotiating credit agreement waivers with its lenders; it expected to make a “significant reduction” of its dividend; and that its Chief Financial Officer had resigned.

On this news, the price of Aceto’s shares plummeted more than 63% on intraday trading on April 19, 2018.

About Kahn Swick & Foti, LLC

KSF, whose partners include the former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

EN
12/05/2018

Underlying

ACETAceto Corporation

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aceto Corporation

MarketLine Department
  • MarketLine Department
EUR 167.02
ACET Aceto Corporati...

Prinova Group LLC - Company Profile and SWOT Analysis

Summary Prinova Group LLC - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Prinova Group LLC (Prinova) manufactures and distributes ingredient and flavor solutions. The company's product portfolio includes acidulants, antioxidants, amino acids, botanical extracts, colors, es...

ACET ACETO CORPORATION
07/20/24 July 20, 2024 1 EN
MarketLine Department
  • MarketLine Department
EUR 167.02
ACET Aceto Corporati...

Disproquima SA - Strategy, SWOT and Corporate Finance Report

Summary Disproquima SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Disproquima SA (Disproquima) is a marketer and distributor of wide range of functional ingredients. The company’s product portfolio includes active pharmaceutical ingredients, vitamins and mine...

ACET ACETO CORPORATION
09/29/23 September 29, 2023 1 EN
Free Trial
ACET Aceto Corporati...

Adicet Bio Inc: 2 directors

A director at Adicet Bio Inc bought 5,000 shares at 2.400USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

ACET ACETO CORPORATION
07/01/23 July 1, 2023 1 EN
 PRESS RELEASE
Free
ACET Aceto Corporati...

ACETO Completes the Sale of Its Chemicals Business Assets

ACETO Completes the Sale of Its Chemicals Business Assets PORT WASHINGTON, N.Y., April 30, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (OTC: ACETQ) announced today that it has completed the previously disclosed sale of its chemicals business assets to an affiliate of New Mountain Capital, a leading growth-oriented investment firm with over $20 billion in assets under management. The purchase price paid in the transaction consisted of cash plus the payment of cure costs and the assumption of certain liabilities.  ACETO used a portion of the proceeds from the transaction to repay 100% of ...

April 30, 2019 1 EN
 PRESS RELEASE
Free
ACET Aceto Corporati...

ACETO to Sell its Chemicals Business Assets to New Mountain Capital

ACETO to Sell its Chemicals Business Assets to New Mountain Capital PORT WASHINGTON, N.Y., April 15, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (OTC: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has agreed to sell its chemicals business assets to an affiliate of New Mountain Capital (“NMC”), a leading growth-oriented investment firm with over $20 billion in assets under management. The asset purchase agreement was entered into following ...

April 15, 2019 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch